M.Y. Mok

909 total citations
11 papers, 671 citations indexed

About

M.Y. Mok is a scholar working on Rheumatology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, M.Y. Mok has authored 11 papers receiving a total of 671 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Rheumatology, 4 papers in Pathology and Forensic Medicine and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in M.Y. Mok's work include Systemic Lupus Erythematosus Research (5 papers), Systemic Sclerosis and Related Diseases (3 papers) and Pulmonary Hypertension Research and Treatments (2 papers). M.Y. Mok is often cited by papers focused on Systemic Lupus Erythematosus Research (5 papers), Systemic Sclerosis and Related Diseases (3 papers) and Pulmonary Hypertension Research and Treatments (2 papers). M.Y. Mok collaborates with scholars based in Hong Kong, China and Canada. M.Y. Mok's co-authors include Chak Sing Lau, Jinling Tang, Albert W. Chan, Yi Ren, W.L. Ng, Wilfred Hing Sang Wong, Man‐Fung Yuen, Wing S. Wong, G.C. Ooi and Wenshu Tang and has published in prestigious journals such as Journal of Internal Medicine, Clinical and Vaccine Immunology and Lupus.

In The Last Decade

M.Y. Mok

11 papers receiving 652 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M.Y. Mok Hong Kong 10 323 251 140 91 77 11 671
Irena Litinsky Israel 12 243 0.8× 372 1.5× 121 0.9× 38 0.4× 92 1.2× 21 651
M. Bunce United Kingdom 16 594 1.8× 111 0.4× 178 1.3× 117 1.3× 42 0.5× 29 974
Shoichiro Irimajiri Japan 13 129 0.4× 300 1.2× 105 0.8× 136 1.5× 34 0.4× 51 642
Yoshio Ozaki Japan 16 585 1.8× 191 0.8× 137 1.0× 185 2.0× 57 0.7× 43 1.0k
Imen Sfar Tunisia 16 251 0.8× 99 0.4× 134 1.0× 124 1.4× 25 0.3× 80 628
Ahmet Emre Eşkazan Türkiye 15 128 0.4× 153 0.6× 84 0.6× 109 1.2× 47 0.6× 130 813
Toshihiko Kaneshige Japan 17 411 1.3× 196 0.8× 201 1.4× 95 1.0× 40 0.5× 37 1.0k
B. Suárez Spain 14 360 1.1× 75 0.3× 194 1.4× 65 0.7× 59 0.8× 25 626
Yousr Gorgi Tunisia 15 241 0.7× 121 0.5× 117 0.8× 110 1.2× 22 0.3× 66 564
Filiz Türe Özdemir Türkiye 15 103 0.3× 128 0.5× 166 1.2× 193 2.1× 26 0.3× 38 625

Countries citing papers authored by M.Y. Mok

Since Specialization
Citations

This map shows the geographic impact of M.Y. Mok's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.Y. Mok with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.Y. Mok more than expected).

Fields of papers citing papers by M.Y. Mok

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.Y. Mok. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.Y. Mok. The network helps show where M.Y. Mok may publish in the future.

Co-authorship network of co-authors of M.Y. Mok

This figure shows the co-authorship network connecting the top 25 collaborators of M.Y. Mok. A scholar is included among the top collaborators of M.Y. Mok based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.Y. Mok. M.Y. Mok is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Lau, Chak Sing, et al.. (2012). Pathogenesis of systemic lupus erythematosus update. Pathology. 44. S39–S39. 2 indexed citations
2.
Chan, Jasper Fuk‐Woo, Min Chen, Owen Tak‐Yin Tsang, et al.. (2010). Disseminated Penicilliosis, Recurrent Bacteremic Nontyphoidal Salmonellosis, and Burkholderiosis Associated with Acquired Immunodeficiency Due to Autoantibody against Gamma Interferon. Clinical and Vaccine Immunology. 17(7). 1132–1138. 81 indexed citations
3.
Yiu, Kai Hang, M.Y. Mok, G.C. Ooi, et al.. (2009). Prevalence and extent of calcification over aorta, coronary and carotid arteries in patients with rheumatoid arthritis. Journal of Internal Medicine. 266(5). 445–452. 64 indexed citations
4.
Mok, M.Y., et al.. (2007). Bosentan use in systemic lupus erythematosus patients with pulmonary arterial hypertension. Lupus. 16(4). 279–285. 15 indexed citations
5.
Mok, M.Y., Sin Yew Wong, Tak Mao Chan, et al.. (2006). Necrotizing fasciitis in rheumatic diseases. Lupus. 15(6). 380–383. 62 indexed citations
6.
Mok, M.Y., Dominic Jack, Chak Sing Lau, et al.. (2004). Antibodies to mannose binding lectin in patients with systemic lupus erythematosus. Lupus. 13(7). 522–528. 31 indexed citations
8.
Mok, M.Y., W.L. Ng, Man‐Fung Yuen, Wilfred Hing Sang Wong, & Chak Sing Lau. (2000). Safety of disease modifying anti-rheumatic agents in rheumatoid arthritis patients with chronic viral hepatitis.. PubMed. 18(3). 363–8. 71 indexed citations
9.
Mok, M.Y., Hung‐Fat Tse, & Chak Sing Lau. (1999). Pulmonary hypertension secondary to systemic lupus erythematosus: prolonged survival following treatment with intermittent low dose iloprost. Lupus. 8(4). 328–331. 14 indexed citations
10.
Mok, M.Y. & Chak Sing Lau. (1998). Protein losing enteropathy and primary Sjögren's syndrome.. PubMed. 15(6). 705–705. 15 indexed citations
11.
Ooi, G.C., Hys Ngan, Wcg Peh, M.Y. Mok, & Msm Ip. (1997). Systemic lupus erythematosus patients with respiratory symptoms: the value of HRCT. Clinical Radiology. 52(10). 775–781. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026